Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Salgado

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Plos One|September 6, 2017
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agentAbiodun D Ogunniyi, Manouchehr Khazandi, Andrew J Stevens, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2026
Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): Results of a Society for Immunotherapy of Cancer multi-institutional reproducibility studyJ S Deutsch, T R Cottrell, K Y Chen, et al.
Cancer Discovery|May 8, 2020
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer MetastasisJosef Leibold, Marcus Ruscetti, Zhen Cao, et al.
ESMO Open|June 10, 2025
Analytical and clinical validation of PATHWAY HER2 (4B5) assay for assessment of HER2-low/HER2-ultralow status and eligibility for trastuzumab deruxtecan in DESTINY-Breast06R Shami, R Salgado, A Bardia, et al.
Genomics Data|October 21, 2015
Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patientsB Haibe-Kains, C Desmedt, A Di Leo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2025
Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effortJ S Deutsch, R A Scolyer, E Burton, et al.
Seminars in Cancer Biology|July 11, 2018
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learningF Klauschen, K-R Müller, A Binder, et al.
Journal of Leukocyte Biology|September 15, 2024
The Escherichia coli TolC efflux pump protein is immunogenic and elicits protective antibodiesThaynara O Silva, Bárbara A Teixeira, Leon V S Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014R Salgado, C Denkert, S Demaria, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Plos One|September 6, 2017
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agentAbiodun D Ogunniyi, Manouchehr Khazandi, Andrew J Stevens, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2026
Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): Results of a Society for Immunotherapy of Cancer multi-institutional reproducibility studyJ S Deutsch, T R Cottrell, K Y Chen, et al.
Cancer Discovery|May 8, 2020
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer MetastasisJosef Leibold, Marcus Ruscetti, Zhen Cao, et al.
ESMO Open|June 10, 2025
Analytical and clinical validation of PATHWAY HER2 (4B5) assay for assessment of HER2-low/HER2-ultralow status and eligibility for trastuzumab deruxtecan in DESTINY-Breast06R Shami, R Salgado, A Bardia, et al.
Genomics Data|October 21, 2015
Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patientsB Haibe-Kains, C Desmedt, A Di Leo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2025
Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effortJ S Deutsch, R A Scolyer, E Burton, et al.
Seminars in Cancer Biology|July 11, 2018
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learningF Klauschen, K-R Müller, A Binder, et al.
Journal of Leukocyte Biology|September 15, 2024
The Escherichia coli TolC efflux pump protein is immunogenic and elicits protective antibodiesThaynara O Silva, Bárbara A Teixeira, Leon V S Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014R Salgado, C Denkert, S Demaria, et al.
Pageof 22